nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Hypersensitivity—Bleomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Deferiprone—Infection—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Deferiprone—Pain—Ifosfamide—testicular cancer	0.00137	0.00137	CcSEcCtD
Deferiprone—Cardiac failure—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Deferiprone—Nervous system disorder—Cisplatin—testicular cancer	0.00135	0.00135	CcSEcCtD
Deferiprone—Asthenia—Bleomycin—testicular cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Convulsion—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Dehydration—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Skin disorder—Cisplatin—testicular cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Hypertension—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Osteoarthritis—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Diplopia—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Pain in extremity—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Hyperhidrosis—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Pruritus—Bleomycin—testicular cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Nausea—Vinblastine—testicular cancer	0.00132	0.00132	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Deferiprone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Deferiprone—Pancreatitis—Methotrexate—testicular cancer	0.00131	0.00131	CcSEcCtD
Deferiprone—Discomfort—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Deferiprone—Hypotension—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Deferiprone—Hypersensitivity—Dactinomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Urticaria—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Abdominal pain—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Body temperature increased—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Pancytopenia—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Anaphylactic shock—Etoposide—testicular cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00126	0.00126	CcSEcCtD
Deferiprone—Infection—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Deferiprone—Asthenia—Dactinomycin—testicular cancer	0.00125	0.00125	CcSEcCtD
Deferiprone—Neutropenia—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Deferiprone—Dehydration—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Deferiprone—Skin disorder—Etoposide—testicular cancer	0.00123	0.00123	CcSEcCtD
Deferiprone—Hyperhidrosis—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Deferiprone—Pancreatitis—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Deferiprone—Photosensitivity reaction—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Deferiprone—Decreased appetite—Cisplatin—testicular cancer	0.0012	0.0012	CcSEcCtD
Deferiprone—Diarrhoea—Dactinomycin—testicular cancer	0.0012	0.0012	CcSEcCtD
Deferiprone—Pneumonia—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Vomiting—Bleomycin—testicular cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Infestation NOS—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Infestation—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Deferiprone—Pancytopenia—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Hypotension—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Rash—Bleomycin—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Pain—Cisplatin—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Dermatitis—Bleomycin—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Hypersensitivity—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Deferiprone—Neutropenia—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Deferiprone—Asthenia—Ifosfamide—testicular cancer	0.00115	0.00115	CcSEcCtD
Deferiprone—Photosensitivity reaction—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Deferiprone—Weight increased—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Deferiprone—Pruritus—Ifosfamide—testicular cancer	0.00113	0.00113	CcSEcCtD
Deferiprone—Pancreatitis—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Deferiprone—Somnolence—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Deferiprone—Hepatobiliary disease—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Deferiprone—Epistaxis—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Deferiprone—Pneumonia—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Deferiprone—Nausea—Bleomycin—testicular cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Infestation NOS—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Infestation—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Vomiting—Dactinomycin—testicular cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Agranulocytosis—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Rash—Dactinomycin—testicular cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Decreased appetite—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Diarrhoea—Ifosfamide—testicular cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Pancytopenia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Deferiprone—Body temperature increased—Cisplatin—testicular cancer	0.00109	0.00109	CcSEcCtD
Deferiprone—Fatigue—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Deferiprone—Jaundice—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Pain—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Neutropenia—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Deferiprone—Hepatitis—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Deferiprone—Pharyngitis—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Deferiprone—Urinary tract disorder—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Hepatobiliary disease—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Weight increased—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Epistaxis—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Urethral disorder—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Deferiprone—Nausea—Dactinomycin—testicular cancer	0.00104	0.00104	CcSEcCtD
Deferiprone—Agranulocytosis—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Deferiprone—Pneumonia—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Gastrointestinal pain—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Infestation—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Infestation NOS—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Deferiprone—Vomiting—Ifosfamide—testicular cancer	0.00102	0.00102	CcSEcCtD
Deferiprone—Hypersensitivity—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Deferiprone—Rash—Ifosfamide—testicular cancer	0.00101	0.00101	CcSEcCtD
Deferiprone—Dermatitis—Ifosfamide—testicular cancer	0.00101	0.00101	CcSEcCtD
Deferiprone—Urticaria—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Deferiprone—Jaundice—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Deferiprone—Abdominal pain—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Deferiprone—Body temperature increased—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Deferiprone—Hepatitis—Epirubicin—testicular cancer	0.000998	0.000998	CcSEcCtD
Deferiprone—Eye disorder—Methotrexate—testicular cancer	0.000997	0.000997	CcSEcCtD
Deferiprone—Asthenia—Cisplatin—testicular cancer	0.000991	0.000991	CcSEcCtD
Deferiprone—Pharyngitis—Epirubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Deferiprone—Cardiac disorder—Methotrexate—testicular cancer	0.00099	0.00099	CcSEcCtD
Deferiprone—Urinary tract disorder—Epirubicin—testicular cancer	0.000986	0.000986	CcSEcCtD
Deferiprone—Oedema peripheral—Epirubicin—testicular cancer	0.000983	0.000983	CcSEcCtD
Deferiprone—Connective tissue disorder—Epirubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Deferiprone—Urethral disorder—Epirubicin—testicular cancer	0.000978	0.000978	CcSEcCtD
Deferiprone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000973	0.000973	CcSEcCtD
Deferiprone—Epistaxis—Doxorubicin—testicular cancer	0.00097	0.00097	CcSEcCtD
Deferiprone—Angiopathy—Methotrexate—testicular cancer	0.000968	0.000968	CcSEcCtD
Deferiprone—Immune system disorder—Methotrexate—testicular cancer	0.000963	0.000963	CcSEcCtD
Deferiprone—Mediastinal disorder—Methotrexate—testicular cancer	0.000961	0.000961	CcSEcCtD
Deferiprone—Agranulocytosis—Doxorubicin—testicular cancer	0.00096	0.00096	CcSEcCtD
Deferiprone—Chills—Methotrexate—testicular cancer	0.000957	0.000957	CcSEcCtD
Deferiprone—Nausea—Ifosfamide—testicular cancer	0.000951	0.000951	CcSEcCtD
Deferiprone—Diarrhoea—Cisplatin—testicular cancer	0.000945	0.000945	CcSEcCtD
Deferiprone—Mental disorder—Methotrexate—testicular cancer	0.000934	0.000934	CcSEcCtD
Deferiprone—Eye disorder—Epirubicin—testicular cancer	0.000933	0.000933	CcSEcCtD
Deferiprone—Hypersensitivity—Etoposide—testicular cancer	0.000932	0.000932	CcSEcCtD
Deferiprone—Malnutrition—Methotrexate—testicular cancer	0.000928	0.000928	CcSEcCtD
Deferiprone—Cardiac disorder—Epirubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Deferiprone—Hepatitis—Doxorubicin—testicular cancer	0.000924	0.000924	CcSEcCtD
Deferiprone—Pharyngitis—Doxorubicin—testicular cancer	0.000917	0.000917	CcSEcCtD
Deferiprone—Urinary tract disorder—Doxorubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Deferiprone—Oedema peripheral—Doxorubicin—testicular cancer	0.00091	0.00091	CcSEcCtD
Deferiprone—Asthenia—Etoposide—testicular cancer	0.000908	0.000908	CcSEcCtD
Deferiprone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Deferiprone—Angiopathy—Epirubicin—testicular cancer	0.000906	0.000906	CcSEcCtD
Deferiprone—Urethral disorder—Doxorubicin—testicular cancer	0.000905	0.000905	CcSEcCtD
Deferiprone—Immune system disorder—Epirubicin—testicular cancer	0.000902	0.000902	CcSEcCtD
Deferiprone—Mediastinal disorder—Epirubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Deferiprone—Back pain—Methotrexate—testicular cancer	0.000898	0.000898	CcSEcCtD
Deferiprone—Chills—Epirubicin—testicular cancer	0.000896	0.000896	CcSEcCtD
Deferiprone—Pruritus—Etoposide—testicular cancer	0.000895	0.000895	CcSEcCtD
Deferiprone—Vomiting—Cisplatin—testicular cancer	0.000878	0.000878	CcSEcCtD
Deferiprone—Mental disorder—Epirubicin—testicular cancer	0.000874	0.000874	CcSEcCtD
Deferiprone—Rash—Cisplatin—testicular cancer	0.000871	0.000871	CcSEcCtD
Deferiprone—Dermatitis—Cisplatin—testicular cancer	0.00087	0.00087	CcSEcCtD
Deferiprone—Malnutrition—Epirubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Deferiprone—Diarrhoea—Etoposide—testicular cancer	0.000866	0.000866	CcSEcCtD
Deferiprone—Eye disorder—Doxorubicin—testicular cancer	0.000863	0.000863	CcSEcCtD
Deferiprone—Cardiac disorder—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Deferiprone—Back pain—Epirubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Deferiprone—Angiopathy—Doxorubicin—testicular cancer	0.000838	0.000838	CcSEcCtD
Deferiprone—Immune system disorder—Doxorubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Deferiprone—Mediastinal disorder—Doxorubicin—testicular cancer	0.000832	0.000832	CcSEcCtD
Deferiprone—Chills—Doxorubicin—testicular cancer	0.000829	0.000829	CcSEcCtD
Deferiprone—Nausea—Cisplatin—testicular cancer	0.00082	0.00082	CcSEcCtD
Deferiprone—Mental disorder—Doxorubicin—testicular cancer	0.000809	0.000809	CcSEcCtD
Deferiprone—Convulsion—Methotrexate—testicular cancer	0.000804	0.000804	CcSEcCtD
Deferiprone—Vomiting—Etoposide—testicular cancer	0.000804	0.000804	CcSEcCtD
Deferiprone—Malnutrition—Doxorubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Deferiprone—Rash—Etoposide—testicular cancer	0.000798	0.000798	CcSEcCtD
Deferiprone—Dermatitis—Etoposide—testicular cancer	0.000797	0.000797	CcSEcCtD
Deferiprone—Headache—Etoposide—testicular cancer	0.000792	0.000792	CcSEcCtD
Deferiprone—Arthralgia—Methotrexate—testicular cancer	0.00079	0.00079	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000785	0.000785	CcSEcCtD
Deferiprone—Discomfort—Methotrexate—testicular cancer	0.000781	0.000781	CcSEcCtD
Deferiprone—Back pain—Doxorubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Deferiprone—Anaphylactic shock—Methotrexate—testicular cancer	0.000758	0.000758	CcSEcCtD
Deferiprone—Convulsion—Epirubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Deferiprone—Infection—Methotrexate—testicular cancer	0.000753	0.000753	CcSEcCtD
Deferiprone—Nausea—Etoposide—testicular cancer	0.000751	0.000751	CcSEcCtD
Deferiprone—Hypertension—Epirubicin—testicular cancer	0.00075	0.00075	CcSEcCtD
Deferiprone—Nervous system disorder—Methotrexate—testicular cancer	0.000743	0.000743	CcSEcCtD
Deferiprone—Arthralgia—Epirubicin—testicular cancer	0.00074	0.00074	CcSEcCtD
Deferiprone—Skin disorder—Methotrexate—testicular cancer	0.000736	0.000736	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000735	0.000735	CcSEcCtD
Deferiprone—Hyperhidrosis—Methotrexate—testicular cancer	0.000733	0.000733	CcSEcCtD
Deferiprone—Discomfort—Epirubicin—testicular cancer	0.000731	0.000731	CcSEcCtD
Deferiprone—Anaphylactic shock—Epirubicin—testicular cancer	0.000709	0.000709	CcSEcCtD
Deferiprone—Hypotension—Methotrexate—testicular cancer	0.000708	0.000708	CcSEcCtD
Deferiprone—Infection—Epirubicin—testicular cancer	0.000704	0.000704	CcSEcCtD
Deferiprone—Convulsion—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Deferiprone—Nervous system disorder—Epirubicin—testicular cancer	0.000695	0.000695	CcSEcCtD
Deferiprone—Hypertension—Doxorubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00069	0.00069	CcSEcCtD
Deferiprone—Skin disorder—Epirubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Deferiprone—Hyperhidrosis—Epirubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Deferiprone—Arthralgia—Doxorubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00068	0.00068	CcSEcCtD
Deferiprone—Discomfort—Doxorubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Deferiprone—Somnolence—Methotrexate—testicular cancer	0.000674	0.000674	CcSEcCtD
Deferiprone—Dyspepsia—Methotrexate—testicular cancer	0.000667	0.000667	CcSEcCtD
Deferiprone—Hypotension—Epirubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Deferiprone—Decreased appetite—Methotrexate—testicular cancer	0.000659	0.000659	CcSEcCtD
Deferiprone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000656	0.000656	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000654	0.000654	CcSEcCtD
Deferiprone—Fatigue—Methotrexate—testicular cancer	0.000653	0.000653	CcSEcCtD
Deferiprone—Infection—Doxorubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Deferiprone—Pain—Methotrexate—testicular cancer	0.000648	0.000648	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000646	0.000646	CcSEcCtD
Deferiprone—Nervous system disorder—Doxorubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Deferiprone—Skin disorder—Doxorubicin—testicular cancer	0.000637	0.000637	CcSEcCtD
Deferiprone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Deferiprone—Somnolence—Epirubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Deferiprone—Dyspepsia—Epirubicin—testicular cancer	0.000624	0.000624	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methotrexate—testicular cancer	0.00062	0.00062	CcSEcCtD
Deferiprone—Decreased appetite—Epirubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Deferiprone—Hypotension—Doxorubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Deferiprone—Fatigue—Epirubicin—testicular cancer	0.000611	0.000611	CcSEcCtD
Deferiprone—Pain—Epirubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Deferiprone—Urticaria—Methotrexate—testicular cancer	0.000602	0.000602	CcSEcCtD
Deferiprone—Abdominal pain—Methotrexate—testicular cancer	0.000599	0.000599	CcSEcCtD
Deferiprone—Body temperature increased—Methotrexate—testicular cancer	0.000599	0.000599	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Deferiprone—Somnolence—Doxorubicin—testicular cancer	0.000583	0.000583	CcSEcCtD
Deferiprone—Gastrointestinal pain—Epirubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Deferiprone—Dyspepsia—Doxorubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Deferiprone—Decreased appetite—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Deferiprone—Fatigue—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Deferiprone—Urticaria—Epirubicin—testicular cancer	0.000563	0.000563	CcSEcCtD
Deferiprone—Pain—Doxorubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Deferiprone—Abdominal pain—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Deferiprone—Body temperature increased—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Deferiprone—Hypersensitivity—Methotrexate—testicular cancer	0.000558	0.000558	CcSEcCtD
Deferiprone—Asthenia—Methotrexate—testicular cancer	0.000544	0.000544	CcSEcCtD
Deferiprone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000537	0.000537	CcSEcCtD
Deferiprone—Pruritus—Methotrexate—testicular cancer	0.000536	0.000536	CcSEcCtD
Deferiprone—Hypersensitivity—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Deferiprone—Urticaria—Doxorubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
Deferiprone—Body temperature increased—Doxorubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Deferiprone—Abdominal pain—Doxorubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Deferiprone—Diarrhoea—Methotrexate—testicular cancer	0.000518	0.000518	CcSEcCtD
Deferiprone—Asthenia—Epirubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Deferiprone—Pruritus—Epirubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Deferiprone—Diarrhoea—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Deferiprone—Hypersensitivity—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Deferiprone—Vomiting—Methotrexate—testicular cancer	0.000482	0.000482	CcSEcCtD
Deferiprone—Rash—Methotrexate—testicular cancer	0.000478	0.000478	CcSEcCtD
Deferiprone—Dermatitis—Methotrexate—testicular cancer	0.000477	0.000477	CcSEcCtD
Deferiprone—Headache—Methotrexate—testicular cancer	0.000475	0.000475	CcSEcCtD
Deferiprone—Asthenia—Doxorubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Deferiprone—Pruritus—Doxorubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Deferiprone—Vomiting—Epirubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Deferiprone—Nausea—Methotrexate—testicular cancer	0.00045	0.00045	CcSEcCtD
Deferiprone—Diarrhoea—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Deferiprone—Rash—Epirubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Deferiprone—Dermatitis—Epirubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Deferiprone—Headache—Epirubicin—testicular cancer	0.000444	0.000444	CcSEcCtD
Deferiprone—Nausea—Epirubicin—testicular cancer	0.000421	0.000421	CcSEcCtD
Deferiprone—Vomiting—Doxorubicin—testicular cancer	0.000417	0.000417	CcSEcCtD
Deferiprone—Rash—Doxorubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Deferiprone—Dermatitis—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Deferiprone—Headache—Doxorubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Deferiprone—Nausea—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
